JNJ 10335572

Drug Profile

JNJ 10335572

Latest Information Update: 25 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Developer Johnson & Johnson Pharmaceutical Research & Development LLC
  • Class Antidiarrhoeals
  • Mechanism of Action Opioid delta receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diarrhoea

Most Recent Events

  • 25 Sep 2006 Discontinued - Preclinical for Diarrhoea in USA (unspecified route)
  • 28 Jan 2003 Data presented at the 32nd annual meeting of the Society for Neuroscience (SFN) has been added to the Digestive System Disorders pharmacodynamics section
  • 22 Dec 2002 Preclinical trials in Diarrhoea in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top